世界のカンナビス市場(~2026年):用途別(医療、レクリエーション)、製品種類別(花、濃縮物)、調合別(THC優性、CBD優性、バランスTHC・CBD)、地域別(北米、南米、ヨーロッパ、その他)

■ 英語タイトル:Cannabis Market by Application (Medical and Recreational), Product Type (Flowers and Concentrates), Compound (THC-dominant, CBD-dominant, and Balanced THC & CBD), and Region (North America, South America, Europe, and RoW) - Global Forecast to 2026

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:FB6762)■ 発行会社/調査会社:MarketsandMarkets
■ 商品コード:FB6762
■ 発行日:2021年2月20日
■ 調査対象地域:グローバル
■ 産業分野:食品・飲料
■ ページ数:218
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のカンナビス市場(~2026年):用途別(医療、レクリエーション)、製品種類別(花、濃縮物)、調合別(THC優性、CBD優性、バランスTHC・CBD)、地域別(北米、南米、ヨーロッパ、その他)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

マーケッツアンドマーケッツ社は世界のカンナビス市場規模が2020年205億ドルから2026年904億ドルまで、年平均28.0%成長すると予想しています。本調査レポートでは、カンナビスの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、用途別(医療、レクリエーション)分析、製品種類別(花、濃縮物、その他)分析、調合別(THC優性、CBD優性、バランスTHC・CBD)分析、地域別分析、競争状況、企業情報などをまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のカンナビス市場規模:用途別(医療、レクリエーション)
・世界のカンナビス市場規模:製品種類別(花、濃縮物、その他)
・世界のカンナビス市場規模:調合別(THC優性、CBD優性、バランスTHC・CBD)
・世界のカンナビス市場規模:地域別
・競争状況
・企業情報

“According to MarketsandMarkets, the cannabis market is estimated to be valued at USD 20.5 billion in 2020 and is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0 %, in terms of value.”
The market is primarily driven by factors such as growing medical applications of cannabis and increasing legalization of cannabis and rise in social acceptance of marijuana. North America accounted for the largest market share in the cannabis market owing to the increasing legalization of cannabis for both medical and recreational purposes across the region. However, one of the restraining factors in the growth of cannabis market is complex regulatory structure to produce and use cannabis.

“By application, the recreational segment is projected to grow at the highest CAGR during the forecast period.”
Based on application, the recreational segment is expected to be the fastest-growing during the forecast period. This segment is rapidly growing as it is highly demanded and consumed by the consumers. Also, high demand for recreational cannabis can translate into larger market if it gets legalized across various regions.

“By compound, the THC-dominant segment is estimated to account for the largest share.”
The THC-dominant segment of the cannabis is dominating the market. The dominance of this segment is majorly attributed to the fact that THC is the psychoactive substance in cannabis products that is responsible for the high. It also provides important medical benefits and is effective in relieving nausea, appetite loss, and insomnia.

“The Europe region is projected to grow at the highest CAGR during the forecast period”
Europe is projected to be the fastest-growing market for the period considered for this study, due to the increasing legalization of medical cannabis in the region. Also, the healthcare system present in several European countries covers the health expenditure of most patients in this region, further contributing to the growth of cannabis market.
The cannabis market is segmented region-wise, with a detailed analysis of each region. These regions include North America, South America, Europe, and RoW (Israel and Australia).

Break-up of Primaries
 By Company Type: Tier 1 – 40%, Tier 2 – 25% and Tier 3 – 35%
 By Designation: Manager- 35%, CXOs– 40%, and Executives – 25%
 By Region: North America- 40%, Asia Pacific – 25%, Europe – 15%, and South America & Africa – 20%

Leading players profiled in this report include the following:
• Canopy Growth Corporation (Canada)
• Aurora Cannabis Inc. (Canada)
• MedMen (US)
• Terra Tech Corp. (US)
• Aphria Inc. (Canada)
• VIVO Cannabis Inc. (Canada)
• The Cronos Group (Canada)
• Medical Marijuana Inc. (US)
• Stenocare (Denmark)
• Tikun Olam (Israel)
• Organigrams Holding Inc. (Canada)
• Cresco Labs (US)
• Maricann Group Inc. (Canada)
• Indiva (Canada)
• Hexo Corp. (Canada)
• Ecofibre Limited (Australia)
• Curaleaf Holdings (US)
• Harvest Health and Recreation (US)
• Green Thumb Industries (US)
• TerrAscend (Canada)

Research Coverage
This report segments the cannabis market on the basis of product type, application, compound, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, pricing insights, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the cannabis market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Reasons to buy this report
• To get a comprehensive overview of the cannabis market
• To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them
• To gain insights about the major countries/regions, in which the cannabis market is flourishing

*** レポート目次(コンテンツ)***

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
FIGURE 1 CANNABIS MARKET SEGMENTATION 27
1.4 REGIONS COVERED 27
TABLE 1 INCLUSIONS & EXCLUSIONS 28
1.5 PERIODIZATION CONSIDERED 28
1.6 CURRENCY CONSIDERED 29
TABLE 2 USD EXCHANGE RATES CONSIDERED, 2017–2020 29
1.7 VOLUME UNIT CONSIDERED 29
1.8 STAKEHOLDERS 30
1.9 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 2 CANNABIS MARKET: RESEARCH DESIGN 32
FIGURE 3 KEY DATA FROM PRIMARY SOURCES 33
FIGURE 4 KEY PRIMARY INSIGHTS 34
2.2 MARKET SIZE ESTIMATION 35
2.2.1 APPROACH ONE (BASED ON APPLICATION, BY REGION) 35
2.2.2 APPROACH TWO (BASED ON THE GLOBAL MARKET) 36
2.3 DATA TRIANGULATION 37
FIGURE 5 DATA TRIANGULATION METHODOLOGY 37
2.4 ASSUMPTIONS FOR THE STUDY 38
2.5 LIMITATIONS OF THE STUDY 39
2.6 SCENARIO-BASED MODELING 39
2.7 COVID-19 HEALTH ASSESSMENT 40
FIGURE 6 COVID-19: THE GLOBAL PROPAGATION 40
FIGURE 7 COVID-19 PROPAGATION: SELECT COUNTRIES 41
2.8 COVID-19 ECONOMIC ASSESSMENT 42
FIGURE 8 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020 42
2.8.1 COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT 43
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 43
FIGURE 10 SCENARIOS IN TERMS OF RECOVERY OF THE GLOBAL ECONOMY 44

3 EXECUTIVE SUMMARY 46
TABLE 3 CANNABIS MARKET SHARE SNAPSHOT, 2020 VS. 2026 (USD BILLION) 46
FIGURE 11 IMPACT OF COVID-19 ON THE CANNABIS MARKET SIZE, BY SCENARIO,
2020 VS. 2021 (USD BILLION) 47
FIGURE 12 CANNABIS MARKET SIZE, BY APPLICATION, 2020 VS. 2026 (USD BILLION) 48
FIGURE 13 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2020 VS. 2026 (USD BILLION) 49
FIGURE 14 CANNABIS MARKET SIZE, BY COMPOUND, 2020 VS. 2026 (USD BILLION) 50
FIGURE 15 CANNABIS MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 2019 51
4 PREMIUM INSIGHTS 52
4.1 ATTRACTIVE OPPORTUNITIES IN THE CANNABIS MARKET 52
FIGURE 16 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATES OPPORTUNITIES IN THE GLOBAL MARKET 52
4.2 CANNABIS MARKET: MAJOR REGIONAL SUBMARKETS 53
FIGURE 17 NORTH AMERICA WAS THE LARGEST MARKET GLOBALLY FOR CANNABIS
IN 2019 53
4.3 EUROPE: CANNABIS MARKET, BY KEY PRODUCT TYPE & COUNTRY 54
FIGURE 18 GERMANY TO ACCOUNT FOR THE LARGEST SHARE IN THE EUROPEAN MARKET IN 2020 54
4.4 CANNABIS MARKET, BY APPLICATION 54
FIGURE 19 THE RECREATIONAL SEGMENT PROJECTED TO DOMINATE THE CANNABIS MARKET DURING THE FORECAST PERIOD 54
4.5 CANNABIS MARKET, BY COMPOUND 55
FIGURE 20 TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND PROJECTED TO DOMINATE THE CANNABIS MARKET DURING THE FORECAST PERIOD 55
4.6 CANNABIS MARKET, BY PRODUCT TYPE & REGION 56
FIGURE 21 NORTH AMERICA TO DOMINATE THE MARKET FOR CANNABIS DURING THE FORECAST PERIOD 56
4.7 CANNABIS MARKET COVID-19 IMPACT, BY SCENARIO 57
FIGURE 22 COVID-19 IMPACT ON THE CANNABIS MARKET: COMPARISON OF PRE-
AND POST-COVID-19 SCENARIOS 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 23 CANNABIS MARKET DYNAMICS 58
5.2.1 DRIVERS 59
5.2.1.1 Growth in the medical applications of cannabis 59
5.2.1.2 Increase in legalization of cannabis and rise in social acceptance of marijuana 59
TABLE 4 NORTH AMERICA: NUMBER OF CANNABIS USERS, BY KEY COUNTRY,
2019 (MILLION PEOPLE) 60
TABLE 5 EUROPE: NUMBER OF CANNABIS USERS, BY KEY COUNTRY,
2019 (MILLION PEOPLE) 61
5.2.1.3 Increase in R&D and technological innovation 62
5.2.2 RESTRAINTS 62
5.2.2.1 Complex regulatory structure for the usage of cannabis 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Product development via research and novel product delivery solutions 63
5.2.3.2 Emergence of cannabis legalization in Asia Pacific 63
5.2.4 CHALLENGES 64
5.2.4.1 Intensive energy consumption and maintaining product consistency for the cultivation of cannabis 64
5.2.4.2 Myths associated with cannabis 64
5.2.4.3 Declining prices as products get commoditized 65
5.3 COVID-19 IMPACT ON THE CANNABIS MARKET 65
TABLE 6 GLOBAL AVERAGE PRICE OF CANNABIS, BY PRODUCT TYPE,
2018 VS 2019 (USD/KG) 66
5.4 PATENT ANALYSIS 66
TABLE 7 SOME OF THE PATENTS PERTAINING TO CANNABIS, 2019–2020 66
5.5 VALUE CHAIN 70
FIGURE 24 CANNABIS MARKET: VALUE CHAIN 70
5.6 MARKET MAP FOR CANNABIS 71
FIGURE 25 CANNABIS MARKET ECOSYSTEM MAP 71
5.7 KEY MARKETS FOR IMPORT/EXPORT 72
5.7.1 TETRAHYDROCANNABINOLS 72
TABLE 8 TOP 10 IMPORTERS AND EXPORTERS OF TETRAHYDROCANNABINOLS,
2017 (KG) 72
TABLE 9 TOP 10 IMPORTERS AND EXPORTERS OF TETRAHYDROCANNABINOLS,
2018 (KG) 72
TABLE 10 TOP 10 IMPORTERS AND EXPORTERS OF TETRAHYDROCANNABINOLS,
2019 (KG) 73
5.8 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 11 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS 73
5.9 YC-YCC SHIFT 74
FIGURE 26 YC & YCC SHIFT FOR THE CANNABIS MARKET 74
6 CANNABIS MARKET, BY APPLICATION 75
6.1 INTRODUCTION 76
FIGURE 27 CANNABIS MARKET SHARE (VALUE), BY APPLICATION, 2020 VS 2026 76
TABLE 12 CANNABIS MARKET SIZE, BY APPLICATION, 2016–2017 (USD MILLION) 76
TABLE 13 CANNABIS MARKET SIZE, BY APPLICATION, 2018–2026 (USD MILLION) 77
6.1.1 COVID-19 IMPACT ON THE CANNABIS MARKET, BY APPLICATION 77
6.1.1.1 Optimistic Scenario 77
TABLE 14 OPTIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2021 (USD MILLION) 77
6.1.1.2 Realistic Scenario 77
TABLE 15 REALISTIC SCENARIO: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2021 (USD MILLION) 77
6.1.1.3 Pessimistic Scenario 78
TABLE 16 PESSIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2021 (USD MILLION) 78
6.2 MEDICAL 78
6.2.1 INCREASE IN CANNABIS USE TREATMENT OF VARIOUS AILMENTS DRIVES THE DEMAND FOR MEDICAL CANNABIS 78
6.2.1.1 Pain Management 78
6.2.1.2 Neurological Health Management 78
6.2.1.3 Mental Health Management 79
6.2.1.4 Other Medical Applications 79
TABLE 17 MEDICAL CANNABIS MARKET SIZE, BY REGION, 2016–2017 (USD MILLION) 79
TABLE 18 MEDICAL CANNABIS MARKET SIZE, BY REGION, 2018–2026 (USD MILLION) 79
6.3 RECREATIONAL 80
6.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH 80
TABLE 19 RECREATIONAL CANNABIS MARKET SIZE, BY REGION,
2016–2017 (USD MILLION) 80
TABLE 20 RECREATIONAL CANNABIS MARKET SIZE, BY REGION,
2018–2026 (USD MILLION) 80
7 CANNABIS MARKET, BY PRODUCT TYPE 81
7.1 INTRODUCTION 82
FIGURE 28 CANNABIS MARKET SHARE (VALUE), BY PRODUCT TYPE, 2020 VS 2026 82
TABLE 21 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2017 (USD MILLION) 82
TABLE 22 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2026 (USD MILLION) 83
TABLE 23 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2026 (TON) 83
7.1.1 COVID-19 IMPACT ON THE CANNABIS MARKET, BY PRODUCT TYPE 83
7.1.1.1 Optimistic Scenario 83
TABLE 24 OPTIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2021 (USD MILLION) 83
7.1.1.2 Realistic Scenario 84
TABLE 25 REALISTIC SCENARIO: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2021 (USD MILLION) 84
7.1.1.3 Pessimistic Scenario 84
TABLE 26 PESSIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION) 84
7.2 FLOWERS 84
7.2.1 WIDER AVAILABILITY AND VERSATILITY OF FLOWER PRODUCTS DRIVE THE MARKET FOR THESE PRODUCTS 84
TABLE 27 CANNABIS FLOWERS MARKET SIZE, BY REGION, 2016–2017 (USD MILLION) 85
TABLE 28 CANNABIS FLOWERS MARKET SIZE, BY REGION, 2018–2026 (USD MILLION) 85

7.3 CONCENTRATES 85
7.3.1 VARIOUS DELIVERY METHODS HAVE MADE THE MARKET FOR CANNABIS CONCENTRATES EXTREMELY CONSUMER-FRIENDLY 85
TABLE 29 CANNABIS CONCENTRATES MARKET SIZE, BY REGION,
2016–2027 (USD MILLION) 86
TABLE 30 CANNABIS CONCENTRATES MARKET SIZE, BY REGION,
2018–2026 (USD MILLION) 86
7.4 OTHER PRODUCT TYPES 86
7.4.1 LARGE NUMBER OF FOOD & BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES 86
TABLE 31 OTHER CANNABIS PRODUCT TYPES MARKET SIZE, BY REGION,
2016–2017 (USD MILLION) 87
TABLE 32 OTHER CANNABIS PRODUCT TYPES MARKET SIZE, BY REGION,
2018–2026 (USD MILLION) 87
8 CANNABIS MARKET, BY COMPOUND 88
8.1 INTRODUCTION 89
FIGURE 29 CANNABIS MARKET SHARE (VALUE), BY COMPOUND, 2020 VS 2026 89
TABLE 33 CANNABIS MARKET SIZE, BY COMPOUND, 2016–2017 (USD MILLION) 89
TABLE 34 CANNABIS MARKET SIZE, BY COMPOUND, 2018–2026 (USD MILLION) 90
8.1.1 COVID-19 IMPACT ON THE CANNABIS MARKET, BY COMPOUND 90
8.1.1.1 Optimistic Scenario 90
TABLE 35 OPTIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2021 (USD MILLION) 90
8.1.1.2 Realistic Scenario 90
TABLE 36 REALISTIC SCENARIO: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2021 (USD MILLION) 90
8.1.1.3 Pessimistic Scenario 91
TABLE 37 PESSIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2021 (USD MILLION) 91
8.2 TETRAHYDROCANNABINOL (THC)-DOMINANT 91
8.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS COULD HELP PROPEL THE MARKET FOR THC-DOMINANT CANNABIS 91
TABLE 38 THC-DOMINANT CANNABIS MARKET SIZE, BY REGION,
2016–2017 (USD MILLION) 91
TABLE 39 THC-DOMINANT CANNABIS MARKET SIZE, BY REGION,
2018–2026 (USD MILLION) 92
8.3 CANNABIDIOL (CBD)-DOMINANT 92
8.3.1 USAGE OF CANNABIDIOL FOR MEDICINAL APPLICATIONS DRIVES THE MARKET FOR CBD-DOMINANT CANNABIS PRODUCTS 92
TABLE 40 CBD-DOMINANT CANNABIS MARKET SIZE, BY REGION,
2016–2017 (USD MILLION) 92
TABLE 41 CBD-DOMINANT CANNABIS MARKET SIZE, BY REGION,
2018–2026 (USD MILLION) 93

8.4 BALANCED THC & CBD 93
8.4.1 THE MARKET FOR BALANCED THC & CBD STRAINS WITNESSES GROWTH AS CBD DIMINISHES THE PSYCHOACTIVE PROPERTIES OF THC 93
TABLE 42 BALANCED THC & CBD CANNABIS MARKET SIZE, BY REGION,
2016–2017 (USD MILLION) 93
TABLE 43 BALANCED THC & CBD CANNABIS MARKET SIZE, BY REGION,
2018–2026 (USD MILLION) 94
9 CANNABIS MARKET, BY REGION 95
9.1 INTRODUCTION 96
TABLE 44 AVERAGE PRICE OF CANNABIS, BY REGION, 2018 & 2019 (USD/KG) 96
FIGURE 30 REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2020–2026 97
9.2 GLOBAL REGULATORY OVERVIEW 98
FIGURE 31 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL AND RECREATIONAL CANNABIS 98
FIGURE 32 NEW REVENUE POCKET FOR CANNABIS MARKET 99
TABLE 45 CANNABIS MARKET SIZE, BY REGION, 2016–2017 (USD MILLION) 99
TABLE 46 CANNABIS MARKET SIZE, BY REGION, 2018–2026 (USD MILLION) 99
TABLE 47 CANNABIS MARKET SIZE, BY REGION, 2018–2026 (TON) 100
9.2.1 COVID-19 IMPACT ON THE CANNABIS MARKET, BY REGION 100
9.2.1.1 Optimistic Scenario 100
TABLE 48 OPTIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY REGION,
2018–2021 (USD MILLION) 100
9.2.1.2 Realistic Scenario 100
TABLE 49 REALISTIC SCENARIO: CANNABIS MARKET SIZE, BY REGION,
2018–2021 (USD MILLION) 100
9.2.1.3 Pessimistic Scenario 101
TABLE 50 PESSIMISTIC SCENARIO: CANNABIS MARKET SIZE, BY REGION,
2018–2021 (USD MILLION) 101
9.3 NORTH AMERICA 101
FIGURE 33 NORTH AMERICA: CANNABIS MARKET SNAPSHOT 102
9.3.1 NORTH AMERICA: REGULATORY OVERVIEW, BY COUNTRY 103
9.3.1.1 US 103
FIGURE 34 US CANNABIS REGULATORY OVERVIEW 103
9.3.1.1.1 Nevada 103
9.3.1.1.2 Colorado 104
9.3.1.1.3 Maine 104
9.3.1.1.4 California 104
9.3.1.1.5 Massachusetts 104
9.3.1.1.6 Alaska 104
9.3.1.1.7 Oregon 104
9.3.1.1.8 Washington 105
9.3.1.1.9 Washington DC 105
9.3.1.1.10 Vermont 105
9.3.1.2 Canada 105
TABLE 51 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY,
2016–2017 (USD MILLION) 105
TABLE 52 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY,
2018–2026 (USD MILLION) 106
TABLE 53 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2017 (USD MILLION) 106
TABLE 54 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 106
TABLE 55 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2017 (USD MILLION) 106
TABLE 56 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 107
TABLE 57 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2017 (USD MILLION) 107
TABLE 58 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 107
9.3.2 US 108
9.3.2.1 Increase in the legalization of both medical and recreational cannabis in several states to drive the market in the US 108
TABLE 59 US: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2026 (USD MILLION) 108
TABLE 60 US: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2026 (USD MILLION) 108
TABLE 61 US: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 108
9.3.3 CANADA 109
9.3.3.1 Legalization of recreational cannabis in 2018 to fuel the market growth 109
TABLE 62 CANADA: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 109
TABLE 63 CANADA: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 109
TABLE 64 CANADA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 110
9.3.4 MEXICO 110
9.3.4.1 Legalization of medical cannabis leads to the growth of the Mexican cannabis market 110
TABLE 65 MEXICO: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 111
TABLE 66 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 111
TABLE 67 MEXICO: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 111
9.4 EUROPE 112
9.4.1 EUROPE: REGULATORY OVERVIEW, BY COUNTRY 112
9.4.1.1 Germany 112
9.4.1.2 Italy 113
9.4.1.3 Denmark 113
9.4.1.4 Netherlands 113
9.4.1.5 France 113
FIGURE 35 EUROPE: CANNABIS MARKET SNAPSHOT 114
TABLE 68 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2026 (USD MILLION) 115
TABLE 69 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2017 (USD MILLION) 115
TABLE 70 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 115
TABLE 71 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2017 (USD MILLION) 116
TABLE 72 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 116
TABLE 73 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2017 (USD MILLION) 116
TABLE 74 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 116
9.4.2 GERMANY 117
9.4.2.1 Complete health insurance coverage for the use of medical cannabis is driving the German market 117
TABLE 75 GERMANY: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 117
TABLE 76 GERMANY: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 117
TABLE 77 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 118
9.4.3 ITALY 118
9.4.3.1 Increase in demand for cannabis and the issuance of import licenses to drive the Italian cannabis market 118
TABLE 78 ITALY: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 118
TABLE 79 ITALY: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 119
TABLE 80 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2026 (USD MILLION) 119
9.4.4 DENMARK 119
9.4.4.1 The huge demand for medical cannabis is expected to drive the Danish medical cannabis market 119
TABLE 81 DENMARK: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 119
TABLE 82 DENMARK: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 120
TABLE 83 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 120
9.4.5 NETHERLANDS 120
9.4.5.1 Strong infrastructure and rise in export of medical cannabis to other countries is driving the market in the Netherlands 120
TABLE 84 NETHERLANDS: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 121
TABLE 85 NETHERLANDS: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 121
TABLE 86 THE NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 121
9.4.6 FRANCE 122
9.4.6.1 Liberalization of policies related to the cannabis market will drive the French cannabis market 122
TABLE 87 FRANCE: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 122
TABLE 88 FRANCE: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 122
TABLE 89 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 122
9.4.7 REST OF EUROPE 123
TABLE 90 REST OF EUROPE: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 123
TABLE 91 REST OF EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 123
TABLE 92 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 123
9.5 SOUTH AMERICA 124
9.5.1 SOUTH AMERICA: REGULATORY OVERVIEW, BY COUNTRY 124
9.5.1.1 Chile 124
9.5.1.2 Colombia 124
9.5.1.3 Uruguay 124
TABLE 93 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY,
2016–2017 (USD MILLION) 124
TABLE 94 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY,
2018–2026 (USD MILLION) 125
TABLE 95 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2017 (USD MILLION) 125
TABLE 96 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 125
TABLE 97 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2017 (USD MILLION) 125
TABLE 98 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 126
TABLE 99 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2017 (USD MILLION) 126
TABLE 100 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 126
9.5.2 CHILE 127
9.5.2.1 Rise in awareness among consumers about the benefits offered by medical cannabis is driving the market in Chile 127
TABLE 101 CHILE: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 127
TABLE 102 CHILE: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 127
TABLE 103 CHILE: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 128
9.5.3 COLOMBIA 128
9.5.3.1 Increased cannabis license distribution to companies will drive the Colombian cannabis market 128
TABLE 104 COLOMBIA: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 128
TABLE 105 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 129
TABLE 106 COLOMBIA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 129
9.5.4 URUGUAY 129
9.5.4.1 The fully legalized cannabis industry with eased regulations is driving the market in Uruguay 129
TABLE 107 URUGUAY: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 129
TABLE 108 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 130
TABLE 109 URUGUAY: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 130
9.5.5 REST OF SOUTH AMERICA 130
9.5.5.1 Legalization of medical cannabis is the major driving factor for Rest of South America 130
TABLE 110 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2026 (USD MILLION) 131
TABLE 111 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 131
TABLE 112 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2026 (USD MILLION) 131
9.6 ROW 132
9.6.1 ROW: REGULATORY OVERVIEW, BY COUNTRY 132
9.6.1.1 Israel 132
9.6.1.2 Australia 132
TABLE 113 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2026 (USD MILLION) 132
TABLE 114 ROW: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2017 (USD MILLION) 133
TABLE 115 ROW: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 133
TABLE 116 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2017 (USD MILLION) 133
TABLE 117 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2026 (USD MILLION) 133
TABLE 118 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2017 (USD MILLION) 134
TABLE 119 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 134
9.6.2 ISRAEL 134
9.6.2.1 Technical innovations coupled with liberal government policies to drive the market in Israel 134
TABLE 120 ISRAEL: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 135
TABLE 121 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 135
TABLE 122 ISRAEL: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 135
9.6.3 AUSTRALIA 136
9.6.3.1 Improvement in access to medical cannabis is projected to drive the growth 136
TABLE 123 AUSTRALIA: CANNABIS MARKET SIZE, BY APPLICATION,
2018–2026 (USD MILLION) 136
TABLE 124 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND,
2018–2026 (USD MILLION) 136
TABLE 125 AUSTRALIA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2018–2026 (USD MILLION) 137
10 COMPETITIVE LANDSCAPE 138
10.1 OVERVIEW 138
10.2 MARKET EVALUATION FRAMEWORK 139
FIGURE 36 MARKET EVALUATION FRAMEWORK, 2018–2020 139
10.3 MARKET SHARE ANALYSIS, 2019 139
FIGURE 37 MARKET SHARE ANALYSIS OF MAJOR PLAYERS IN THE CANNABIS MARKET, 2019 140
10.4 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 140
10.4.1 STARS 140
10.4.2 EMERGING LEADERS 140
10.4.3 PERVASIVE PLAYERS 141
10.4.4 EMERGING COMPANIES 141
FIGURE 38 CANNABIS MARKET: COMPANY EVALUATION QUADRANT,
2019 (OVERALL MARKET) 141
10.4.5 PRODUCT FOOTPRINTS 142
TABLE 126 CANNABIS MARKET: COMPANY PRODUCT TYPE FOOTPRINT 142
TABLE 127 CANNABIS MARKET: COMPANY COMPOUND FOOTPRINT 142
TABLE 128 CANNABIS MARKET: COMPANY REGIONAL FOOTPRINT 142
10.5 COMPANY EVALUATION QUADRANT (OTHER PLAYERS) 143
10.5.1 PROGRESSIVE COMPANIES 143
10.5.2 STARTING BLOCKS 143
10.5.3 RESPONSIVE COMPANIES 143
10.5.4 DYNAMIC COMPANIES 143
FIGURE 39 CANNABIS MARKET: COMPANY EVALUATION QUADRANT FOR
OTHER PLAYERS, 2019 144
10.6 COVID-19-SPECIFIC COMPANY RESPONSE 144
10.7 COMPETITIVE SCENARIO 145
10.7.1 EXPANSIONS & INVESTMENTS 145
TABLE 129 EXPANSIONS, 2020 145
10.7.2 NEW PRODUCT LAUNCHES 146
TABLE 130 NEW PRODUCT LAUNCHES, 2020 146
10.7.3 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS 147
TABLE 131 AGREEMENTS AND PARTNERSHIPS, 2020 147
10.7.4 MERGERS & ACQUISITIONS 148
TABLE 132 MERGERS & ACQUISITIONS, 2020 148
11 COMPANY PROFILES 149
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
11.1 KEY PLAYERS 149
11.1.1 CANOPY GROWTH CORPORATION 149
FIGURE 40 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT 149
FIGURE 41 CANOPY GROWTH CORPORATION: SWOT ANALYSIS 157
11.1.2 AURORA CANNABIS INC. 158
FIGURE 42 AURORA CANNABIS INC.: COMPANY SNAPSHOT 158
FIGURE 43 AURORA CANNABIS INC.: SWOT ANALYSIS 164
11.1.3 MEDMEN 165
FIGURE 44 MEDMEN: COMPANY SNAPSHOT 165
FIGURE 45 MEDMEN: SWOT ANALYSIS 167
11.1.4 TERRA TECH CORP. 168
FIGURE 46 TERRA TECH CORP.: COMPANY SNAPSHOT 168
FIGURE 47 TERRA TECH CORP.: SWOT ANALYSIS 170
11.1.5 APHRIA INC. 171
FIGURE 48 APHRIA INC.: COMPANY SNAPSHOT 171
FIGURE 49 APHRIA INC.: SWOT ANALYSIS 174
11.1.6 VIVO CANNABIS INC. 176
FIGURE 50 VIVO CANNABIS INC.: COMPANY SNAPSHOT 176
11.1.7 THE CRONOS GROUP 181
FIGURE 51 THE CRONOS GROUP: COMPANY SNAPSHOT 181
11.1.8 MEDICAL MARIJUANA INC. 184
FIGURE 52 MEDICAL MARIJUANA INC.: COMPANY SNAPSHOT 184
11.1.9 STENOCARE 188
11.1.10 TIKUN OLAM 190
11.2 OTHER PLAYERS 192
11.2.1 ORGANIGRAMS HOLDING INC. 192
FIGURE 53 ORGANIGRAMS HOLDING INC.: COMPANY SNAPSHOT 192
11.2.2 CRESCO LABS 195
FIGURE 54 CRESCO LABS: COMPANY SNAPSHOT 195
11.2.3 INDIVA LIMITED 198
FIGURE 55 INDIVA LIMITED: COMPANY SNAPSHOT 198
11.2.4 CURALEAH HOLDINGS INC. 201
FIGURE 56 CURALEAF HOLDINGS INC.: COMPANY SNAPSHOT 201
11.2.5 HEXO CORP. 205
FIGURE 57 HEXO CORP.: COMPANY SNAPSHOT 205
11.2.6 ECOFIBRE LIMITED 208
FIGURE 58 ECOFIBRE LIMITED: COMPANY SNAPSHOT 208
11.2.7 HARVEST HEALTH AND RECREATION 209
FIGURE 59 HARVEST HEALTH AND RECREATION: COMPANY SNAPSHOT 209
11.2.8 GREEN THUMB INDUSTRIES 211
FIGURE 60 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT 211
11.2.9 MARICANN GROUP INC. 213
11.2.10 TERRASCEND 214
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX 216
12.1 DISCUSSION GUIDE 216
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 221
12.3 AVAILABLE CUSTOMIZATIONS 223
12.4 RELATED REPORTS 223
12.5 AUTHOR DETAILS 224



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(FB6762 )"世界のカンナビス市場(~2026年):用途別(医療、レクリエーション)、製品種類別(花、濃縮物)、調合別(THC優性、CBD優性、バランスTHC・CBD)、地域別(北米、南米、ヨーロッパ、その他)" (英文:Cannabis Market by Application (Medical and Recreational), Product Type (Flowers and Concentrates), Compound (THC-dominant, CBD-dominant, and Balanced THC & CBD), and Region (North America, South America, Europe, and RoW) - Global Forecast to 2026)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。